Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
VENUSREM

Venus Remedies Share Price

 

 

Venus Remedies live price: ₹950. It opened at ₹925 vs previous close ₹932; intraday high/low: ₹952/₹914. The 50 & 200 DMA stand at ₹908.94/₹711.82.

Venus Remedies Performance

  • Today's Low
  • ₹914
  • Today's High
  • ₹952
  • 52 Week Low
  • ₹305
  • 52 Week High
  • ₹1,089
  • Open Price₹925
  • Previous Close₹932
  • Volume30,688
  • 50 DMA₹908.94
  • 100 DMA₹829.08
  • 200 DMA₹711.82

Venus Remedies Chart

Investment Returns

  • Over 1 Month -7.26%
  • Over 3 Month + 21.01%
  • Over 6 Month + 71.44%
  • Over 1 Year + 195.77%

Smart Investing Starts Here Start SIP with Venus Remedies for Steady Growth!

Invest Now

Venus Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 16.6
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 1,270
  • P/B Ratio
  • 2
  • Average True Range
  • 52.9
  • EPS
  • 57.09
  • Dividend Yield
  • 0
  • MACD Signal
  • 21.03
  • RSI
  • 47.61
  • MFI
  • 31.34

Venus Remedies Financials

Venus Remedies Technicals

EMA & SMA

Current Price
₹950.00
+ 18.3 (1.96%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹959.69
  • 50 Day
  • ₹908.94
  • 100 Day
  • ₹829.08
  • 200 Day
  • ₹711.82

Resistance and Support

945.9 Pivot Speed
  • R3 1,022.50
  • R2 1,001.70
  • R1 966.70
  • S1 910.90
  • S2 890.10
  • S3 855.10

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Venus Remedies has an operating revenue of Rs. 699.88 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 11% is healthy, ROE of 8% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 44% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 96 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 63 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Venus Remedies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-29 Quarterly Results & Others To consider other business matters.
2025-11-10 Quarterly Results
2025-08-01 Quarterly Results
2025-07-08 Others Inter-alia, to consider 1. Notice of 36th Annual General Meeting. 2. Boards Report for Financial Year 2024-2025. 3. Other business matters.
2025-05-26 Audited Results

Venus Remedies Shareholding Pattern

41.76%
2.8%
44.4%
11.04%

Venus Remedies FAQs

Venus Remedies share price is ₹950 As on 13 May, 2026 | 12:17

The Market Cap of Venus Remedies is ₹1269.9 Cr As on 13 May, 2026 | 12:17

The P/E ratio of Venus Remedies is 16.6 As on 13 May, 2026 | 12:17

The PB ratio of Venus Remedies is 2 As on 13 May, 2026 | 12:17

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23